RESP® Biosensor
Transforming respiratory care and research with real-world insights on lung sounds
Continuous Auscultation:
Novel Insights into Lung Health
Traditional auscultation with a stethoscope has been the gold standard for assessing lung health for over a century, with abnormal events, such as cough, wheezing, rhonchi, or crackles providing reliable indicators of blockage and other problems of the airways.
As auscultation has been limited to episodic, in-person exams, Strados Labs developed the RESP® Biosensor to extend the temporal and geographic range of stethoscopes, providing clinicians and researchers with unprecedented access to patients’ lung sounds.
Our technology, backed by numerous publications and awards, is used globally to measure treatment response in drug development and research studies as well as in clinical settings to provide greater control and management of chronic respiratory diseases.
Clients & Partners
The RESP® Biosensor: Technology Overview
- Clinically validated accuracy, with equivalent performance to Littman 3200 stethoscope
- Continuous collection of lung sounds such as cough and wheeze to offer objective data on respiratory status passively and remotely
- Patient-friendly device that reduces burden on patients while improving clinician efficiency
FDA 510(k) Cleared, CE Mark, HIPAA Compliant
How It Works
An end-to-end solution for remote monitoring of lung sounds
RESP® Biosensor
Patient receives system and adheres device to their chest with a provided adhesive
Strados™ Mobile App
Patient starts device recording via mobile app, with lung sound data securely transferred to the app
Strados™ Cloud
Cloud securely stores data where lung sounds are identified by either algorithms or trained annotators
Track Patient Progress Objectively and Remotely
Patient reports include accurate, time-stamped data on signs and symptoms such as coughing and wheezing, allowing for greater diagnostics and insight into treatment response.
*Machine learning algorithms not FDA-cleared and for investigational use only
RESP® Fills a Gap in the Standard of Care
While standard-of-care such as pulmonary function tests and patient-reported outcomes continue to provide value in patient care and research, our technology offers a novel measure to provide the most complete respiratory picture.
| RESP® Biosensor | Episodic Auscultation | Pulmonary Function Tests | Patient Self-Reporting | Cough Monitors | |
|---|---|---|---|---|---|
| Continuous | |||||
| Objective Data | |||||
| Passive | |||||
| Lung Sound Collection | |||||
| Low Patient Burden |
Publications
View our clinical validation, whitepapers and case studies
Poster Presentation, American Thoracic Society, 2022
Strados Labs: An Efficient Process to Acquire and Characterize Clinically Validated Respiratory Information
Poster Presentation, IEEE Signal Processing Symposium, 2019
Results of Clinical Performance Testing of a Novel Wearable Stethoscope in Chronic Lung Diseases
Poster Presentation, American Thoracic Society, 2022
For Healthcare
Improve surveillance and disease management of respiratory patients from hospital to home
For Research
Gain stronger, objective insight into subject treatment response in drug development and clinical trials
OVERVIEW VIDEO
Learn more about the benefits of Strados Labs’ RESP Biosensor System
Frequently Asked Questions (FAQ)
Is the RESP® Biosensor reimbursable?
The RESP® Biosensor is reimbursable under RPM and RTM codes.
Is the RESP® Biosensor designed for continuous long-term monitoring?
Yes. The RESP® Biosensor was designed for long-term, continuous remote monitoring with the goal of detecting changes in lung sounds passively ranging from 4 – 24 hours per day.
Which care settings is the RESP® Biosensor intended for?
The RESP® Biosensor is designed to be used across multiple care settings, including in-patient, transitional care, post-acute discharge, outpatient, pulmonary rehabilitation and hospital-at-home. The device is also used in drug development to measure treatment response in clinical trials.